A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais.AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences.
Nitayaphan S, Khamboonruang C, Sirisophana N, Morgan P, Chiu J, Duliege AM, Chuenchitra C, Supapongse T, Rungruengthanakit K, deSouza M, Mascola JR, Boggio K, Ratto-Kim S, Markowitz LE, Birx D, Suriyanon V, McNeil JG, Brown AE, Michael RA.
Nitayaphan S, et al. Among authors: mcneil jg.
Vaccine. 2000 Feb 14;18(15):1448-55. doi: 10.1016/s0264-410x(99)00421-1.
Vaccine. 2000.
PMID: 10618542
Clinical Trial.